Impact of the 2020 China Diabetes Society Guideline on the Prevalence of Diabetes Mellitus and Eligibility for Antidiabetic Treatment in China

PURPOSE: This study aimed to estimate the impact of the 2020 China Diabetes Society’s (CDS) guideline on the prevalence of diabetes mellitus and eligibility for antidiabetic treatment in China. MATERIAL AND METHODS: Baseline data from the China Health and Retirement Longitudinal Study (CHARLS, 2011–...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Guoshuai, Zhu, Ni, Qiu, Lin, Yan, Hong, Zeng, Lingxia, Wang, Duolao, Dang, Shaonong, Li, Zhaoqing, Kang, Yijun, Chen, Tao, Li, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520447/
https://www.ncbi.nlm.nih.gov/pubmed/34675626
http://dx.doi.org/10.2147/IJGM.S331948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520447/
https://www.ncbi.nlm.nih.gov/pubmed/34675626
http://dx.doi.org/10.2147/IJGM.S331948

Ejemplares similares